Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;53(5):637-41.
doi: 10.1016/j.jadohealth.2013.08.002.

Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011

Mark A Schmidt  1 , Rachel Gold, Samantha K Kurosky, Matthew F Daley, Stephanie A Irving, Julianne Gee, Allison L Naleway
Affiliations

Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011

Mark A Schmidt et al. J Adolesc Health. 2013 Nov.

Abstract

Purpose: The Advisory Committee on Immunization Practices recommended quadrivalent human papillomavirus vaccine (HPV4) for use in females in June 2006 and in males in October 2009. The objective of our study was to describe HPV4 uptake, single-dose coverage, and completion of the three-dose series among those 9-26 years of age, after the respective female and male vaccine licensures through June 2011.

Methods: The study population included members of eight managed care organizations participating in the Vaccine Safety Datalink; we abstracted demographic and comprehensive vaccine information from electronic health records.

Results: We found one-dose coverage increasing throughout the study period, to a high of 37.7% among females and 1.3% among males in June 2011. Among those receiving at least one HPV4 dose, three-dose series completion was 42% for females and 30.2% for males.

Conclusions: Our results demonstrate low initiation and completion of the HPV4 series among those recommended to receive the vaccine. Although consistent with previous studies, these results highlight the continued need to develop, implement, and monitor strategies to increase HPV4 vaccine initiation and completion in younger adolescents to achieve maximum impact in reducing the burden of cervical cancer and other HPV-related diseases.

Keywords: Gardasil; HPV vaccines; Papillomavirus vaccines; Vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Number of HPV vaccine doses administered, by sex, July 2006–June 2011.
Figure 2.
Figure 2.
HPV vaccine one-dose coverage among females, by age and date, July 2006–June 2011.
Figure 3.
Figure 3.
Completion of the three-dose HPV series in one year, by sex and quarter of index dose, July 2006–June 2011.
See this image and copyright information in PMC

References

    1. Lowy DR, Solomon D, Hildesheim A, et al. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008; 113(Suppl. 7):1980–93. - PMC - PubMed
    1. Subramanya D, Grivas PD. HPV and cervical cancer: Updates on an established relationship. Postgrad Med 2008;120:7–13. - PubMed
    1. American Cancer Society. Cancer facts & figures 2011. Atlanta, GA: American Cancer Society; 2011.
    1. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705–8. - PubMed
    1. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the U.S. Cancer 2008;113(Suppl. 10):2892–900. - PMC - PubMed

Publication types

MeSH terms

Substances